Insights

It’s no secret that there are major issues in the healthcare industry, including breakdowns in doctor-patient communication, delayed test results, and information gaps. Even after consulting with...

Biomeme has announced its participation in a collaborative fight against antimicrobial resistance and antibiotic misuse, focusing on better diagnostic testing. With the Antibacterial Resistance...

We have a very clear goal as a company: to improve global health for humans, animals, and the environment. We do this by creating technology that helps clinicians make informed decisions so that they...

We are happy to announce our participation in the highly anticipated AACC Scientific Meeting & Clinical Lab Expo, taking place in Anaheim, CA. This event presents an incredible opportunity for us to...

About MRIGlobal MRIGlobal improves the health and safety of people everywhere by addressing some of the world’s greatest threats and complex biological, chemical, and engineering challenges. Founded...

Biomeme recently announced the completed acquisition of Predigen. The announcement brings together Predigen's combined decades of host response research with Biomeme's portable PCR test solutions to...

FIND, the global alliance for diagnostics, announced on December 20, 2021 a US$21 million investment to accelerate the development, manufacturing, and launch of affordable, multi-pathogen, molecular...

Through in silico analysis, we’ve confirmed Biomeme’s SARS-Cov-2 assay detects all current variants of concern and variants of interest including delta and omicron. Omicron was first identified in...

Biomeme is excited to announce that we have signed a definitive agreement to acquire Predigen, a spin-out from Duke University and global leader in the development of host gene expression signatures...